Home ›
Trademark Categories ›
Pharmaceuticals ›
2018 ›
CA ›
CANNAPHEN
Trademark search for:
CANNAPHEN
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2018-10-23 — Application filed
2018-11-01 — Application filed
2018-11-06 — Assigned to examiner
2018-12-20 — Application filed
2019-07-19 — Assigned to examiner
2019-07-22 — Final disposition recorded
2019-07-22 — Final disposition recorded
2019-07-22 — Final disposition recorded
2020-01-21 — Office action issued
2020-01-21 — Correspondence received in law office
2020-01-21 — Teas/email correspondence entered
2020-02-05 — Final disposition recorded
2020-02-05 — Final disposition recorded
2020-02-05 — Final disposition recorded
2020-08-21 — Application abandoned
2020-08-21 — Application abandoned
2020-10-21 — Petition to revive-granted
2020-10-21 — Teas petition to revive received
2020-10-21 — Office action issued
2020-10-22 — Notice of revival - e-mailed
2021-02-01 — Assigned to lie
2021-02-01 — Correspondence received in law office
2021-02-01 — Teas/email correspondence entered
2021-02-18 — Final disposition recorded
2021-02-18 — Final disposition recorded
2021-02-18 — Final disposition recorded
2021-09-01 — Application abandoned
2021-09-01 — Application abandoned
2021-09-01 — Final status recorded
Owner Information
Leading Edge Pharms Inc.
Henderson , NV
Correspondent
Yong Chen LIU, CHEN & HOFFMAN LLP ONE PENN PLAZA, SUITE 2508 NEW YORK, NY 10119 UNITED STATES
Filing Details
Filing Date:
2018-12-20
Status Date:
2021-09-01
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.